Lexeo Therapeutics LXEO
NASDAQ LXEO
$2.80 -0.09 (-3.11%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lexeo Therapeutics (LXEO) Cash & Current Investments (2022 - 2026)

Updated

Lexeo Therapeutics (LXEO) recorded Cash & Current Investments of $211.7 million in Q2 2026, up 59.3% from $132.89 million a year earlier and up 9.7% from the prior quarter.

Analysis

Lexeo Therapeutics (LXEO) Cash & Current Investments (2022 - 2026) Analysis & Trends

At the end of FY2025, Lexeo Therapeutics reported Cash & Current Investments of $246.6 million, up 91.9% from FY2024.

  • Annual Cash & Current Investments has increased for three straight years, with a three-year compound annual growth rate of 47.2% (FY2022 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $128.5 million in FY2024 (+5.8%), $121.47 million in FY2023 (+57.1%) and $77.34 million in FY2022.
  • Quarterly Cash & Current Investments has ranged from $35.45 million in Q3 2023 to $246.6 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has increased for three consecutive quarters, with growth averaging 61.2% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 342.9% in Q3 2024, against a decline of 62.3% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $193.04 million (Q1 2026), $246.6 million (Q4 2025) and $122.76 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Lexeo Therapeutics 239.33 Mn -421.08 Mn - 211.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 211.70 Mn
Mar 31, 2026 193.04 Mn
Dec 31, 2025 246.60 Mn
Sep 30, 2025 122.76 Mn
Jun 30, 2025 132.89 Mn
Mar 31, 2025 106.90 Mn
Dec 31, 2024 128.50 Mn
Sep 30, 2024 157.02 Mn
Jun 30, 2024 175.00 Mn
Mar 31, 2024 195.10 Mn
Dec 31, 2023 121.47 Mn
Sep 30, 2023 35.45 Mn
Dec 31, 2022 77.34 Mn
Sep 30, 2022 94.15 Mn
API Access

Lexeo Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LXEO&period=max&api_key=YOUR_API_KEY